Mr. Andriyko Herchak reports
FINCANNA CAPITAL A ROYALTY COMPANY FOR THE LICENSED US CANNABIS INDUSTRY PROVIDES CORPORATE UPDATE
Fincanna Capital Corp. has provided a year-end update of its portfolio companies and objectives for 2021.
QVI Inc., doing business as The Galley, an 8,300-square-foot state-of-the-art cannabis co-manufacturing facility located in Santa Rosa, Calif., is the company's largest investment and moving forward is anticipated to provide the largest source of royalty revenue to Fincanna. The Galley is a one-stop shop for brands looking for a co-manufacturer to provide large-scale production and packaging for all types of edibles, topicals and tinctures in California. The Galley commenced its first full month of operations in July of this year and has already on boarded approximately 25 established brands, with a growing list of new customers each month.
Most of these current clients are small to mid-size brands, and for the past few months the Galley team has been focusing on securing much larger brands, including both established California brands and high-profile out-of-state brands looking to enter California, the largest market in the world. The Galley is close to formalizing agreements with a number of these large brands, and Fincanna anticipates it will be able to announce further details of these potential clients in early 2021.
The Galley's accomplishments are significant as it positions Fincanna for recurring high-margin royalty revenue. Fincanna expects to start receiving royalty payments from QVI in early 2021.
Cultivation Technologies Inc. (CTI), operating as Coachella Manufacturing, is a multifaceted concentrate manufacturer located in a new, fully licensed 5,200 square ft facility in Palm Desert, Calif. CTI provides state-licensed, award-winning, high-quality BHO concentrates for white label manufacturing, toll processing and packaging to hand-selected brands and cultivators in California with a long list of clients.
CTI has been operating for three years, and Fincanna and started receiving royalties in the second half of 2020. Its seasoned management team is also working on growing their core business and expanding into other large-scale activities that would likely result in a sizable increase in royalty revenues to Fincanna.
eZGreen Compliance operates a Health Insurance Portability and Accountability Act-compliant point-of-sale (POS) software for cannabis dispensaries. This POS software delivers fully integrated management and multistore functionality with state-of-the-art taxation and reporting for single-store, multistore and multistate operators. It is also the only fully HIPAA-compliant POS system and has a very attractive pricing model for dispensary owners.
On Aug. 31, 2020, Fincanna announced the acquisition of ezGreen and in October completed the various items involved in the transition of ownership. Recently, ezGreen commenced a marketing initiative with a highly regarded marketing partner that has excellent relationships with the vast majority of dispensaries throughout California.
Equipment investment -- Fincanna also owns approximately $850,000 (U.S.) of brand new, large-scale extraction and distillation equipment that is in secure storage in California. The company continues talks with several parties to monetize this asset by way of a direct sale, a business investment, a royalty agreement, or a combination of these. Management is confident this will occur in the coming months and look forward to announcing to its shareholders at that time.
2021 outlook -- Management expects to see a sizable increase in royalty revenues which would start generating operating profits that will continue to grow. The company has worked very closely with the management teams of all of its portfolio companies, and their leaders are all exceptionally focused and dedicated to the success of their businesses. While business disruptions due to wildfires and the pandemic delayed operations in 2020, the above investments have navigated through these difficult times and are now well positioned for growth.
On a macro level, the U.S. cannabis industry has also seen some very positive tailwinds. The outcome of the recent U.S. elections can pave the way for very positive ripple effects on the cannabis industry such as decriminalization, the removal of cannabis from Schedule 1 of the Controlled Substances Act and relaxation of banking restrictions, which would pave the way for larger investments into the sector. Any of these should be very positive for Fincanna shareholders. Since the election, there has already been a sizable increase in valuations of cannabis companies operating in the U.S., and the company believes real positive actions for the industry would continue to drive the valuations of these multistate operators and other publicly traded U.S. cannabis businesses.
About Fincanna Capital Corp.
Fincanna is a royalty company that provides growth capital to rapidly emerging private companies operating in the licensed U.S. cannabis industry. The company earns its revenue from royalties paid by its investee companies that are calculated based on a percentage of their total revenues.
Fincanna's scalable royalty model provides an attractive alternative or complement to debt or equity financing for its investee companies. Fincanna is focused on delivering high-impact returns to its shareholders by way of a strategically diversified investment portfolio.
We seek Safe Harbor.
© 2021 Canjex Publishing Ltd. All rights reserved.